StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) company profile

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3030% above fair value
$430.53−7.22 (-1.65%)

Close on Nov 17, 2026Market cap $149.24BP/E 52.1Yield –

About Intuitive Surgical

Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842

Intuitive Surgical develops and provides robotic-assisted surgical platforms and diagnostic technologies designed to advance minimally invasive healthcare. The company manufactures the da Vinci surgical system for a wide range of soft-tissue procedures and the Ion endoluminal system for minimally invasive lung biopsies. Beyond primary robotic hardware, its portfolio encompasses specialized instruments, advanced stapling and energy tools, sterile accessories, educational simulation software, and analytics services. Intuitive primarily serves hospitals, healthcare systems, surgeons, and procedural care teams across general surgery, urology, gynecology, cardiothoracic, and head and neck specialties.

The company deploys its surgical and diagnostic platforms internationally across the United States and global markets. Intuitive supports its customer base through an infrastructure of field service engineers situated throughout the United States, Canada, Europe, and Asia, alongside distributor partnerships worldwide. The organization also maintains dedicated training centers where staff instruct clinicians and care teams on its technologies. The provided text does not mention the location of the company's headquarters.

Summary of the business section of Intuitive Surgical's latest annual report, written by StockData.

Company profile

Company

Legal name
Intuitive Surgical Inc
Founded
1995
Headquarters
Sunnyvale, CA
Address
1020 Kifer Road 94086
Phone
(408) 523-2100
Employees
17,021, Dec 31, 2025
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, San Jose, California

Stock & identifiers

Ticker
ISRG
Exchange
Nasdaq
IPO date
Jun 16, 2000
Shares outstanding
347M, Oct 15, 2026
Public float
$193.90B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
3-for-1, Oct 5, 2021; 3-for-1, Oct 6, 2017; 1-for-2 reverse, Jul 1, 2003
SEC CIK
1035267
CUSIP
46120E602
ISIN
US46120E6023
FIGI
BBG000BJPDZ1
Share class FIGI
BBG001S7XR78
LEI
54930052SRG011710797
EIN
77-0416458

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
David J. RosaChief Executive Officer (CEO), Director247,803
Gary LoebEVP & Chief Legal and Complian6,236
Mark BrosiusEVP & Chief Mfg and Supply Cha457
Fredrik WidmanVP Corporate Controller1,026
Patricia L. WadorsSVP Chief Human Resources Offi0
Iman JeddiSVP & GM da Vinci Platforms &38,737
Myriam CuretEVP & Chief Medical Officer514
Henry L. CharltonEVP & Chief Commercial and Mkt5,972
Jamie SamathEVP & CFO & Enterprise Technol15,366
Brian Edward MillerEVP & Chief Digital Officer5,758
Robert DeSantisEVP & Chief Strategy & Corp Op5,412
Craig H. BarrattDirector27,948
Gary S. GuthartDirector1,258,781
Amy L. LaddDirector179
Lewis ChewDirector1,314
Sreelakshmi KolliDirector1,510
Amal M. JohnsonDirector13,545
Keith R. LeonardDirector901
Jami K. NachtsheimDirector6,902
Joseph C. BeeryDirector3,641
Monica P. ReedDirector2,876
Mark J. RubashDirector16,790

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Dr.Guthart
$18.09M$23.85M$6.44M$287$103
FY2025
Mr.Rosa
$21.00M$26.38M$6.44M$287$103
FY2024$18.20M$42.63M$8.37M$265$104
FY2023$12.45M$22.73M$6.88M$171$99
FY2022$10.35M$1.61M$4.99M$135$105
FY2021$8.06M$17.46M$4.46M$182$137

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsIncentive payOtherTotalvs. prior year
David J. Rosa
Chief Executive Officer
$858.75K$18.67M$1.37M$90.00K$21.00M+53%
Gary S. Guthart, Ph.D.
Executive Chair of the Board of Directors
$866.25K$15.95M$886.16K$387.87K$18.09M-1%
Jamie E. Samath
Executive Vice President, Chief Financial Officer and Enterprise Technology Leader
$683.00K$6.91M$786.82K$12.00K$8.40M+19%
Henry L. Charlton
Executive Vice President and Chief Commercial and Marketing Officer
$670.00K$4.79M$771.84K$12.00K$6.24M-4%
Gary H. Loeb
Executive Vice President and Chief Legal and Compliance Officer
$615.00K$4.25M$708.48K$12.00K$5.59M–
Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
$534.35K$4.52M$462.24K$22.00K$5.54M–

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 17,021 full-time employees, with approximately 2,288 in research and development, 7,625 in manufacturing operations, 4,837 in commercial and service operations, and 2,271 in administrative activities.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?